EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,934,027 | +32.8% | 180,047 | +16.1% | 0.01% | +42.9% |
Q2 2023 | $2,962,642 | -4.1% | 155,031 | -2.6% | 0.01% | -12.5% |
Q1 2023 | $3,090,402 | -7.8% | 159,217 | -23.8% | 0.01% | -11.1% |
Q4 2022 | $3,350,547 | -2.1% | 208,887 | -4.3% | 0.01% | -10.0% |
Q3 2022 | $3,424,000 | -27.4% | 218,373 | -3.6% | 0.01% | -23.1% |
Q2 2022 | $4,718,000 | -37.3% | 226,581 | -31.8% | 0.01% | -23.5% |
Q1 2022 | $7,529,000 | +260.1% | 332,080 | +190.4% | 0.02% | +325.0% |
Q4 2021 | $2,091,000 | +39.9% | 114,366 | +61.7% | 0.00% | +33.3% |
Q3 2021 | $1,495,000 | +7.6% | 70,721 | -7.3% | 0.00% | 0.0% |
Q2 2021 | $1,390,000 | -24.5% | 76,300 | -6.4% | 0.00% | -25.0% |
Q1 2021 | $1,842,000 | -9.0% | 81,521 | -19.2% | 0.00% | 0.0% |
Q4 2020 | $2,024,000 | -23.8% | 100,864 | -7.1% | 0.00% | -33.3% |
Q3 2020 | $2,655,000 | -6.9% | 108,607 | -9.6% | 0.01% | -14.3% |
Q2 2020 | $2,852,000 | +60.6% | 120,163 | +16.5% | 0.01% | +40.0% |
Q1 2020 | $1,776,000 | -7.3% | 103,118 | -5.2% | 0.01% | +25.0% |
Q4 2019 | $1,916,000 | -59.1% | 108,742 | -59.0% | 0.00% | -66.7% |
Q3 2019 | $4,689,000 | -18.6% | 265,111 | -1.6% | 0.01% | -14.3% |
Q2 2019 | $5,757,000 | -18.5% | 269,380 | -9.2% | 0.01% | -17.6% |
Q1 2019 | $7,065,000 | +182.0% | 296,828 | +133.1% | 0.02% | +142.9% |
Q4 2018 | $2,505,000 | -0.4% | 127,357 | -10.3% | 0.01% | +16.7% |
Q3 2018 | $2,515,000 | -54.3% | 141,904 | -44.5% | 0.01% | -62.5% |
Q2 2018 | $5,503,000 | +72.3% | 255,708 | +77.3% | 0.02% | +77.8% |
Q1 2018 | $3,194,000 | +54.0% | 144,212 | +111.4% | 0.01% | +50.0% |
Q4 2017 | $2,074,000 | -17.8% | 68,211 | -34.5% | 0.01% | -14.3% |
Q3 2017 | $2,523,000 | -33.0% | 104,114 | -31.9% | 0.01% | -36.4% |
Q2 2017 | $3,765,000 | +52.3% | 152,890 | +34.0% | 0.01% | +57.1% |
Q1 2017 | $2,472,000 | +28.3% | 114,090 | -11.7% | 0.01% | +16.7% |
Q4 2016 | $1,926,000 | +84.5% | 129,205 | +58.3% | 0.01% | +100.0% |
Q3 2016 | $1,044,000 | +461.3% | 81,614 | +146.5% | 0.00% | +200.0% |
Q3 2015 | $186,000 | +8.1% | 33,104 | -27.8% | 0.00% | 0.0% |
Q2 2015 | $172,000 | – | 45,871 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
AJO, LP | 7,636,882 | $134,561,000 | 0.80% |